Presentation TCT 2023

TCT 423: Long-term Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition with Evolocumab and Aortic Stenosis Events – An Analysis from FOURIER and FOURIER-OLE

Presenter: Prakriti Gaba

October 26, 2023

REGISTER for free or LOG IN to view this content

TCT 423: Long-term Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition with Evolocumab and Aortic Stenosis Events – An Analysis from FOURIER and FOURIER-OLE

Structural Heart

TCT 2023

Aortic Valve

Up Next

Presentation TCT 2023

TCT 327: Immediate versus Staged Complete Revascularization in Patients Presenting with STEMI and Multivessel Disease

Presenter: Roberto Diletti

October 26, 2023

More slides +

Presentation TCT 2023

TCT 705: Feasibility, Safety and Impact on Vascular Complication Management of Radial Use as an Ancillary Access During Transfemoral Transcatheter Aortic Valve Replacement: the TAVI-LITE Experience

Presenter: Enrico Romagnoli

October 26, 2023

Presentation TCT 2023

TCT 665: A Real-World Comparative Analysis of Surgical and Transcatheter Approaches to Tricuspid Regurgitation

Presenter: Federica Gramegna

October 26, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.